Neoantigens Expressed in Ovarian Cancer and Their Uses
Copyright © Targeted News Service 2024
2024-04-02
ALEXANDRIA, Virginia, April 2 -- JANSSEN BIOTECH, INC., Horsham, Pennsylvania has been assigned a patent (No. US 11945881 B2, initially filed Feb. 12, 2021) developed by five inventors Vipul Bhargava, Warrington, Pennsylvania; Vinod Krishna, Philadelphia, Pennsylvania; David J. Pocalyko, Doylestown, Pennsylvania; Pegah Safabakhsh, Jenkintown, Pennsylvania; and Manuel Alejandro Sepulveda, West Windsor, Pennsylvania, for "Neoantigens expressed in ovarian cancer and their uses." . . .